Product Description
250 Mg Tykerb Tablets is a highly effective medication used to treat breast cancer. Each tablet contains 250mg of Lapatinib Ditosylate, a potent tyrosine kinase inhibitor that blocks the action of certain proteins that promote the growth of cancer cells. This medication is manufactured in India and has a shelf life of 2 years. The tablets have a normal fermentation smell and are available for export, supply, and trade.
FAQs of 250 Mg Tykerb Tablets:
Q: What is the active ingredient in 250 Mg Tykerb Tablets?
A: The active ingredient in 250 Mg Tykerb Tablets is Lapatinib Ditosylate.
Q: What is the recommended dosage of this medication?
A: The recommended dosage of 250 Mg Tykerb Tablets is one tablet taken orally once daily, with or without food.
Q: Are there any side effects associated with this medication?
A: Yes, some common side effects of 250 Mg Tykerb Tablets include diarrhea, nausea, vomiting, fatigue, and rash. However, not everyone will experience these side effects.
Q: Can this medication be taken during pregnancy?
A: It is not recommended to take 250 Mg Tykerb Tablets during pregnancy, as it may harm the unborn baby. It is important to talk to your doctor if you are pregnant or planning to become pregnant before taking this medication.
Q: Can this medication be taken with other medications?
A: It is important to inform your doctor of all medications you are currently taking before starting 250 Mg Tykerb Tablets. Some medications may interact with this medication and cause unwanted side effects.